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Abstract
Carbapenem-resistant Klebsiella pneumoniae are a major global threat in healthcare facili-
ties. The propagation of carbapenem resistance determinants can occur through vertical
transmission, with genetic elements being transmitted by the host bacterium, or by horizon-
tal transmission, with the same genetic elements being transferred among distinct bacterial
hosts. This work aimed to track carbapenem resistance transmission by K. pneumoniae in a
healthcare facility. The study involved a polyphasic approach based on conjugation assays,
resistance phenotype and genotype analyses, whole genome sequencing, and plasmid
characterization by pulsed field gel electrophoresis and optical DNA mapping. Out of 40 K.
pneumoniae clinical isolates recovered over two years, five were carbapenem- and multi-
drug-resistant and belonged to multilocus sequence type ST147. These isolates harboured
the carbapenemase encoding blaKPC-3 gene, integrated in conjugative plasmids of 140 kbp
or 55 kbp, belonging to replicon types incFIA/incFIIK or incN/incFIIK, respectively. The two
distinct plasmids encoding the blaKPC-3 gene were associated with distinct genetic lineages,
as confirmed by optical DNA mapping and whole genome sequence analyses. These
results suggested vertical (bacterial strain-based) transmission of the carbapenem-resis-
tance genetic elements. Determination of the mode of transmission of antibiotic resistance
in healthcare facilities, only possible based on polyphasic approaches as described here, is
essential to control resistance propagation.
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Introduction
The discovery of antibiotics during the 20th century led to a decrease in deaths due to infec-
tious diseases. However, today antibiotic resistance is considered a worldwide crisis, with an
increasing number of infections caused by multidrug-resistant bacteria [1, 2]. Carbapenem-
resistant Gram-negative bacteria, in particular Enterobacteriaceae, are a major cause of health-
care associated infections and increasingly disseminated in the environment [3–5]. The species
Klebsiella pneumoniae (K. pneumoniae) comprises the most ubiquitous and threatening carba-
penem-resistant enterobacteria, with high incidence in hospital-acquired urinary tract infec-
tions, pneumonia, septicaemia and soft tissue infections [6–8]. The highly dynamic genome of
K. pneumoniae explains the frequent acquisition of resistance to multiple antibiotics, often
through conjugative horizontal gene transfer involving plasmids with mobilization gene cas-
settes containing antibiotic resistance genes [9, 10]. Due to this ability, K. pneumoniae is fre-
quently pioneering acquisition of antibiotic resistance, putting this species in the front line of
resistance against what at a given moment is considered a last resort drug, as in the cases of last
generation cephalosporins, carbapenems or colistin [11, 12]. Moreover, K. pneumoniae has
been considered a primary reservoir of emerging antibiotic resistance genes. A good example
is the plasmid-associated blaKPC genes, encoding carbapenem resistance, that have rapidly
spread among Enterobacteriaceae [8, 13]. The mosaic plasmid structure, often modified by
genetic recombination events, brings important challenges to most plasmid epidemiology
studies. Nonetheless, the possibility of tracking plasmids occurring in different bacterial hosts,
detected in different patients or environmental niches, may have an important added value to
unveil the major paths of antibiotic-resistance propagation.
Techniques frequently used to characterize plasmids include Pulsed-Field Gel Electropho-
resis in combination with S1 nuclease (S1-PFGE), and PCR-based replicon typing [14]. Fur-
thermore, high throughput DNA sequencing is increasingly used for plasmid identification
and characterization. However, the successful use of such an approach relies on the compari-
son with already known plasmids available in public databases, requires a complicated assem-
bly process demanding advanced bioinformatics efforts, and is an overall time-consuming
process. In addition, the dynamic nature of plasmidomes, including repetitive sequences, pres-
ence of multiple replicons on a single plasmid, and presence of multiple plasmids of similar or
different sizes in a cell, provide challenges to all of the mentioned techniques and might con-
tribute to confusing or inconclusive results, giving room for the development of novel plasmid
characterization methods. Optical DNA mapping (ODM), based on direct visualization of
individual intact plasmid molecules using fluorescence microscopy, has shown great potential
as a rapid and simple method to analyse and compare plasmids [15–18]. In ODM, large DNA
molecules are labelled in a sequence specific fashion and upon stretching in nanofluidic chan-
nels and imaging by fluorescence microscopy [19], a pattern reflecting the underlying DNA
sequence, a barcode, is obtained [20, 21]. The method can distinguish different plasmids in a
sample, based on their sizes and barcodes, which can be used for identification [17] and tracing
[15, 16, 18], for example during a resistance outbreak. Furthermore, using the CRISPR/Cas9
system makes it possible to, in the same experiment, identify a specific (resistance) gene and
determine its location along the plasmid sequence [22]. Thus, detailed information that con-
ventionally would require several different techniques to extract, can be obtained in a single,
rapid experiment. Moreover, the direct inspection of plasmids offers the possibility of investi-
gating plasmid structure rearrangements, such as insertions, deletions or co-integrate forma-
tion, features that may not be easily detected by DNA sequencing techniques, even when long
read techniques are used.
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In the present study, we were interested in assessing the transmission mode of plasmids,
vertical or horizontal, involved in K. pneumoniae carbapenem resistance dissemination in a
hospital setting. A group of five carbapenem-resistant and one carbapenem-susceptible K.
pneumoniae isolates were selected from a larger data set of K. pneumoniae isolates collected
from 2014 to 2016 during routine screening in a healthcare facility in Porto, Portugal. The
wild isolates and the respective transconjugants were characterized by phenotypic and geno-
typic analyses, including ODM analysis and whole genome sequencing. ODM assays proved to
be particularly useful for the identification of plasmids in transconjugants and for characteriz-
ing co-integrates. Two presumable bacterial clones, harbouring two distinct conjugative plas-
mids harbouring the blaKPC-3 gene, could be identified in two distinct years, suggesting
vertical (bacterial) transmission in the healthcare facility.
Material and methods
Isolates and general characterization
All methods were carried out in accordance with relevant guidelines and regulations. The
study was approved by an ethics committee at the Portuguese Institute of Oncology in Porto
(CES 148/020). Clinical samples, including urine, faeces, blood and haemoculture samples
were processed at the Portuguese Institute of Oncology in accordance with the manual for
good laboratory practices implemented in this health unit. There was no treatment of personal
data and the biological samples are not related to any data that allows the identification of indi-
viduals and the ethics committee at the Portuguese Institute of Oncology in Porto therefore
waived the need for consent from the patients.
Five carbapenem-resistant K. pneumoniae isolates were selected from a group of more than
40 multidrug-resistant isolates from urine, faeces or blood samples of hospitalized patients,
collected over a period of 18 months, from 2014 to 2016 in Porto, Portugal. In addition, one
carbapenem-susceptible clinical isolate was included for further epidemiology assessment. Iso-
lates KP1-349 (faeces), KP1-080 (haemoculture), and KP1-388 (urine, isolated 45 days after
the first two) were recovered from patient 1 in 2016 and KP2-448 and KP2-465 (urine, isolated
with an interval of 15 days) from patient 2 in 2015. The selection was based on the fact that
these isolates were carbapenem-resistant, later observed to be due to a blaKPC-3 gene, which
might be transferred by conjugation. Isolate KP3-685 (pleural fluid) was recovered from
patient 3 in 2014, at least five months before the others. This isolate, carbapenem-susceptible
and lacking the blaKPC-3 gene, contained a 150 kbp plasmid that was hypothesized to be a
potential ancestor of the blaKPC-3 gene carrying plasmids, and the isolate was analysed to test
this hypothesis.
The identification of the isolates and the antibiotic susceptibility tests were conducted using
the MicroScan WalkAway (Beckman Coulter), VITEK 2 Compact Systems (bioMérieux) and
disk diffusion method or E-test (MIC Evaluator, Oxoid), respectively. Antibiotic resistance
genes and plasmid replicon types were screened by PCR. The detection of β-lactamase encod-
ing genes blaTEM, blaOXA-1, blaCTX-M and blaSHV, and plasmid replicon types was performed as
previously described [23]. The presence of carbapenemase encoding genes blaKPC, blaVIM and
blaIMP was screened as described by Gootz et al., [24] Bisiklis et al., [25] and Mendes et al., [26]
respectively. The colistin resistance genes mcr-1 and mcr-2 were screened for as described by
Liu et al., [27] and Xavier et al., [28] respectively.
Plasmid number and size, in both wild and transconjugant isolates, were determined by
Pulsed-Field Gel Electrophoresis (PFGE), as previously described [29] and ODM with identifi-
cation of the blaKPC-3 gene on plasmids linearized by CRISPR/Cas9 [22]. The genomes of the
wild carbapenem-resistant K. pneumoniae isolates were characterized based on whole genome
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sequencing. Two wastewater K. pneumoniae isolates, strain SCC.99 and E2FC13 [30, 31] were
used as recipients in conjugation assays.
DNA extraction and sequencing
For DNA extraction, the QIAGEN Plasmid Midi Kit (QIAGEN, Germany) was used according
to the manufacturer’s instructions for low-copy plasmids. Whole genome sequencing of carba-
penem-resistant isolates was based on the Illumina HiSeq method with a read length of 2 x 150
bp. The following raw reads were obtained per isolate: 15 028 352 for KP1-388, 19 221 864 for
KP1-080, 13 676 708 for KP1-349, 16 325 574 for KP2-448 and 12 421 310 for isolate KP2-465.
The quality of the raw reads was checked with FastQC software v0.11.18, the genomes were
assembled using SPAdes v3.11.1 and after the assembly the contigs with low coverage or with a
size below 500 bp were removed. The putative plasmid DNA sequences were extracted using
de novo assembled raw reads with plasmidSPAdes v3.11.1. The Average Nucleotide Identity
(ANI) values between the draft genome and putative plasmid sequences of the five isolates
were calculated using ANI calculator available at http://enve-omics.ce.gatech.edu/ani. Whole
genome sequences were screened to determine: i) the Multilocus Sequence Type (MLST)
through the web-based tool MLST [32]; ii) plasmid replicon type, identified using the plasmid-
Finder tool [33]; iii)) antibiotic resistance genes with the ResFinder tool [34] and the read map-
ping-based tool SRST2, which uses the CARD database for the detection of acquired resistance
genes [35]. The search for the mobile gene elements holding the blaKPC-3 gene was performed
using de novo assembled raw reads with the plasmidSPAdes v3.11.1 software. Plasmid assem-
bly assays used either the total number of reads (min 12 million reads; max 19 million reads)
or 3.5 million reads, aiming at reducing the number of contigs. For further analysis, the contigs
originating from using 3.5 million reads were used. The gene prediction and annotation were
based on the RAST server query (http://rast.nmpdr.org/rast.cgi). The obtained contigs were
screened for the transposon Tn4401, often associated with the blaKPC-3 gene, using the TETy-
per and default parameters [36].
Sequencing data of the carbapenem-resistant K. pneumoniae isolates were deposited at
Sequence Read Archive (SRA) accession number PRJNA588474.
Conjugation assays
Wild carbapenem-resistant K. pneumoniae isolates were tested as donors in conjugation assays
with wastewater isolates (SCC.99 and E2FC13) of the same species as recipients. Strain SCC.99
harboured plasmids of 170 kbp, 70 kbp and 30 kbp, and strain E2FC13 harboured a plasmid of
200 kbp. Conjugation assays were performed as previously described [37]. Briefly, 30˚C over-
night Luria-Bertani (LB) cultures of donor and recipient cells were mixed in a proportion of
1:3 (300 μL of donor cells and 900 μL of recipient cells), centrifuged for 5 min at 10 000 rpm
and suspended in a final volume of 600 μL of LB medium. Potential transconjugants were iso-
lated, after 8 hours incubation at 28 ˚C, on Luria-Bertani agar (LA) supplemented with tetracy-
cline (16 mg/L), for recipient selection, and meropenem (0.25 mg/L) for transconjugant
selection. Transconjugants were further characterized by antibiotic resistance phenotype and
genotype analyses and ODM.
Optical DNA mapping
The plasmid DNA of the wild carbapenem-resistant K. pneumoniae isolates, KP1-388, KP1-
080, KP1-349, KP2-448, KP2-465, the respective transconjugants and the clinical isolate KP3-
685 was extracted as described above. To detect the carbapenem resistance blaKPC-3 gene, plas-
mids were linearized by Cas9 cutting, as described elsewhere [22]. TracrRNA and crRNA with
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a sequence identifying the blaKPC-3 gene (5’ CAACCACCGCATCCGCGCGG 3’) were pur-
chased from GE Healthcare (USA) and re-suspended in 10 mM RNase free Tris- HCl buffer
(Sigma-Aldrich, USA). Guide RNA (gRNA) was created by incubating 0.5 nmol tracrRNA
with 0.5 nmol crRNA in 1 X NEBuffer 3 (New England Biolabs, USA) and 1 X (0.1 μg/μL) BSA
(New England Biolabs, USA) for 30 min at 4˚C. Next, 10 μM (0.05 nmol) of gRNA was incu-
bated with 600 ng of Cas9 (PNA Bio Inc., USA), 1 X NEBuffer 3 and 1 X (0.1 μg/μL) BSA, at
37˚C for 15 min. Finally, 60 ng of plasmid DNA from the clinical isolates or the transconju-
gants, respectively, was added to the mixture, followed by incubation at 37˚C for 1 hour.
Following the Cas9 restriction, the plasmid DNA was stained according to a competitive
binding assay [20, 21] to obtain the sequence-specific pattern of the optical map. Plasmid
DNA (including the Cas9 mixture) was mixed with YOYO-1 (Invitrogen, USA) and netropsin
(Sigma-Aldrich, USA) at molar ratios of 2:1:100 (DNA bp:YOYO-1:netropsin). λ-DNA (48
502 bp, Roche, Switzerland) was included in the sample as an internal size reference. Samples
were mixed in 5 X TBE buffer (Tris-Borate-EDTA, Novex, Invitrogen, USA) and incubated at
50˚C for 30–60 min to accelerate the equilibration of YOYO-1 binding to DNA [38] and sub-
sequently diluted with mQ-water to a final buffer concentration of 0.05 X TBE and 0.15 μM
(basepairs) DNA (0.05 μM plasmid DNA + 0.1 μM λ-DNA). β-mercaptoethanol (Sigma-
Aldrich, USA) was added to the sample at 2.5% (v/v) as an oxygen scavenger to reduce photo-
nicking during visualization.
The plasmid molecules were stretched in nanofluidic channels and the optical maps were
visualized using fluorescence microscopy as previously described [29]. Series of images of both
circular and linear DNA molecules were obtained and used to measure the plasmid size, visu-
alize the sequence specific pattern, and detect the presence of the blaKPC-3 gene. Images were
analysed using an automated, custom-written MatLab-based program as previously described
[22]. In short, the extensions of the DNA molecules were extracted from the microscopy
image stacks and the molecules were clustered based on their size. For a given cluster, the asso-
ciated DNA optical maps, or barcodes, were aligned and averaged to create so called consensus
barcodes. By analysing whether the plasmids were linearized at random positions (due to
mechanical forces or photonicking), or whether all double strand breaks occurred at the same
position (cut by Cas9), the presence of blaKPC-3 was verified and its location along the plasmid
sequence-based barcode was identified from the optical map. Finally, the consensus barcodes
of plasmids from different samples, i.e. the clinical isolates and transconjugants, were com-
pared [18].
The data obtained from the ODM analysis has been uploaded and is available at https://doi.
org/10.5281/zenodo.4442070.
Results
The aims of the study were to localize the carbapenem resistance gene in plasmids, assess if
these plasmids were conjugative and infer if carbapenem-resistance was being transferred ver-
tically or horizontally in this hospital. Plasmid and bacterial host characterization were com-
bined in order to assess vertical or horizontal transmission of the carbapenemase encoding
gene.
Genomic characterization of wild isolates
From a group of 40 K. pneumoniae isolates recovered from patients over a two-year period in
the studied hospital, five were carbapenem-resistant (KP1-388, KP2-448, KP2-465, KP1-080
and KP1-349), and were isolated from distinct biological samples (faeces, urine and blood) of
two patients, at different time points over a period of 18 months. These isolates were blaKPC-
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positive, presented multidrug resistance profiles to β-lactams, aminoglycosides, quinolones,
cephalosporins, sulphonamides and carbapenems, and susceptibility to tetracycline (Table 1).
Although the five isolates belonged to the same MLST group, ST147 (Table 1), based on whole
genome sequence analysis, they could be divided into two groups, one comprising the patient
1 isolates (KP1-388, KP1-080 and KP1-349) and the other the patient 2 isolates (KP2-448 and
KP2-465). Within each group an Average Nucleotide Identity (ANI) value of 100%, and
�99.97% for putative plasmids, was observed (S1 Table). The two groups shared ANI
values� 99.96%, being� 96.67% for putative plasmid sequences. These results suggest that
the two groups of isolates represent two distinct clones, one isolated from patient 1 during
2016 and the other from patient 2 in 2015. The isolates from both patients also differed in the
plasmid replicon types. The isolates from patient 1 (n = 3) had the incFIIK plasmid replicon
type combined with incFIA, whereas the isolates from patient 2 (n = 2) had incFIIK combined
with incN and incFIBK replicon types (Table 2). The plasmid replicon type incN was detected
by both PCR and genome sequence analysis and replicon type incFIBK was detected only by
genome sequence analysis.
The antibiotic resistance gene profile, determined based on whole genome sequence analy-
sis, confirmed that the five carbapenem-resistant isolates carried the blaKPC-3 gene variant.
Moreover, this analysis revealed distinct genetic determinants in the isolates from patient 1
and patient 2, although targeting the same antibiotic classes (Table 2). Specifically, the isolates
from patient 1 carried the blaOXA-9, blaTEM-1, sul2 and dfrA14 genes, while the isolates from
patient 2 harboured the blaOXA-1, qnrB6, sul1 and dfrA27 genes. Also, the genes catB4 and arr-
3, encoding resistance to phenicol and rifampicin, respectively, were observed only in the
genomes of the isolates from patient 2, while streptomycin resistance (srtAB) was found only
in the isolates from patient 1. The blaKPC genes have been described as being frequently associ-
ated with the replicative transposon Tn4401b, a Tn3-based transposon, flanked by two 39 bp
imperfect inverted repeats, composed of two insertion sequences, ISKpn6 and ISKpn7, a trans-
posase gene (tnpA) and a resolvase gene (tnpR) [39]. In all isolates studied here the blaKPC-3
gene was observed to be associated with the Tn4401d isoform, which has a deletion of 67 bp
compared to Tn4401b and the single nucleotide variation C8015T distinguishing blaKPC-3
from blaKPC-2. The isolates from patient 1 had the same five base-pair target site sequence
flanking the left and the right direct repeats of Tn4401d. In the isolates from patient 2, more
than one direct repeat in both flanks were observed, suggesting multiple Tn4401 transposition
events. In addition, the Tn4401d in the isolates from patient 1 was inserted into a Tn1331 ele-
ment composed of the tnpA and tnpR genes and the antibiotic resistance genes aac(6´)-lb,
aadA1, blaOXA-9 and blaTEM-1. A similar hybrid transposon (99.99% nucleotide sequence iden-
tity) has already been described in a incFIA conjugative plasmid harbouring blaKPC-3
(pBK30661) from K. pneumoniae [40]. The Tn4401d and surrounding genes in the isolates
from patient 2 with incFIIK/incN/incFIBK had 100% identity with a incN conjugative plasmid
from Escherichia coli WI1 reported by Beyrouthy et al., [41]. The plasmid profiles, analysed by
both PFGE and ODM, differed between the two groups of isolates. PFGE results revealed two
plasmids, 290 kbp and 140 kbp in size, in the isolates from patient 1 and four plasmids of 150–
160 kbp, 136 kbp, 110 kbp and 55 kbp in the isolates from patient 2 (Fig 1). These plasmids
were also observed by ODM, except for the 290 kbp plasmid in isolate KP1-080, potentially
due to its low abundance or possible fragmentation during the extraction. Given the distinctive
antibiotic resistance phenotypes and genotypes observed, seemingly correlated to the plasmid
replicon types, the different plasmid profiles confirmed that the blaKPC-3 gene was associated
with two discrete plasmids in the isolates from patient 1 and patient 2, respectively. ODM veri-
fied the observation that the blaKPC-3 gene was harboured on the 140 kbp plasmid in the iso-
lates from patient 1, and on the 55 kbp plasmid in the isolates from patient 2 (Fig 2). Analysis
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Fig 1. Pulse-Field Gel Electrophoresis (PFGE) of the plasmids of Klebsiella pneumoniae isolates SC.99 (1), E2FC13
(2), KP1-388 (3), KP1-080 (4), KP1-349 (5), KP2-448 (6), KP2-465 (7), KP3-685 (8), and the plasmids of the
transconjugants E5: KP1-388-SCC.99 (9), F10: KP1-388-E2FC13 (10), C1: KP1-080-E2FC13 (11), A1: KP1-
349-E2FC13 (12), B3: KP2-448-E2FC13 (13), B4: KP2-448-E2FC13 (14), D2: KP2-465-E2FC13 (15). The orange
line represents a sample irrelevant for the study and cropped from the original figure, shown in S1 Fig. In conjugation
assays, the strains used as recipient cells were SC.99 and E2FC13 with three plasmids (170 kbp, 70 kbp, 30 kbp) and
one plasmid (200 kbp), respectively. The isolates used as donor cells were KP1-388, KP1-080 and KP1-349, all with two
plasmids with same sizes (290 kbp and 140 kbp) and KP2-448 and KP2-465, each with four plasmids (160 kbp, 136
kbp, 110 kbp, 55 kbp and 150 kbp, 136 kbp, 110 kbp, 55 kbp, respectively). The isolate KP3-685 has two plasmids (150
kbp, 80 kbp). The transconjugant E5 has four plasmids (170 kbp, 140 kbp, 70 kbp, 30 kbp). The transconjugants F10,
C1 and A1 have two plasmids with same sizes (200 kbp, 140 kbp). The transconjugants B3 and D2 have also the
plasmid of 200 kbp and a plasmid of 55 kbp. The transconjugant B4 has the plasmid of 200 kbp and a plasmid of 170
kbp. The DNA ladder (M) contains Salmonella enterica serovar Braenderup H9812 (ATCC) 239 digested with XbaI.
https://doi.org/10.1371/journal.pone.0247058.g001
Fig 2. Intensity profiles reflecting the optical maps of the plasmids detected in clinical isolates and found to contain the blaKPC-3 gene. (a) The 140 kbp plasmid
detected in isolates KP1-388, KP1-080 and KP1-349. (b) The 55 kbp plasmid detected in isolates KP2-448 and KP2-465. The open circles in the shaded regions
indicate the location of the blaKPC-3 gene. The circle indicating the gene location in KP2-448 in (b) has been shifted vertically for increased visibility.
https://doi.org/10.1371/journal.pone.0247058.g002
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of the intensity profiles (barcodes) obtained by ODM confirmed that the same plasmid was
found in each group of isolates (from patient 1 and 2, respectively). The location of the blaKPC-
3 gene was determined from the linearization position along the plasmid, caused by the specific
cutting by Cas9 [22] and was confirmed to be the same in the plasmids harboured by the dif-
ferent isolates of each group.
The carbapenem-susceptible isolate KP3-685 from 2014, which lacked the blaKPC-3 gene,
was found to have a plasmid with a size (~150 kbp) similar to that of the plasmid harbouring
the blaKPC-3 gene in the isolates from patient 1 (Table 1, Fig 1). We suspected that this plasmid
could be the genetic platform for acquisition of the blaKPC-3 gene. This hypothesis was tested
using the ODM assay, but no similarity between that ~150 kbp plasmid and the blaKPC-3-har-
bouring 140 kbp plasmid could be found (Fig 3a). However, ODM revealed that the second
plasmid, 80 kbp in size, found in isolate KP3-685 had an intensity profile that overlapped in
part with the profiles of the 140 kbp plasmid observed in the isolates from patient 1 and the
136 kbp plasmid observed in the isolates from patient 2 (Table 1, Fig 3b). The 140 kbp plasmid
found in the isolates from patient 1 harbours the blaKPC-3 gene, whereas neither the 136 kbp
plasmid found in the isolates from patient 2 nor the 80 kbp plasmid found in isolate KP3-685
does. Consistently, the similar parts of the intensity profiles of these plasmids does not include
the region where the blaKPC-3 gene is located.
Conjugative plasmids harbouring blaKPC-3
Conjugation assays were used to further test the hypothesis that the blaKPC-3 carrying plasmids,
identified by ODM, could be horizontally transferred and, in case affirmative, if they were
identical to those observed in the wild isolates. In these assays, meropenem was used for selec-
tion of transconjugants.
The five carbapenem-resistant isolates were all found able to transfer the blaKPC-3 gene by
conjugation. With the exception of colistin and ciprofloxacin resistance, all the tested resis-
tance phenotypes were transferred in parallel with carbapenem resistance (Table 1). Consis-
tently, PFGE and ODM analyses showed that transconjugants obtained from tetracycline and
meropenem selection after conjugation assays of wild type isolates with the 290 kbp and 140
kbp plasmids (patient 1) received the latter plasmid, while those resulting from wild isolates
with plasmids of sizes 150–160 kbp, 136 kbp, 110 kbp and 55 kbp (patient 2) received the
smallest plasmid or, as observed in one case, a potential co-integrate with a novel plasmid size
of 170 kbp (Figs 1 and 4–6). Based on PCR plasmid replicon typing, it was possible to conclude
that the transferred 140 kbp plasmid was of plasmid replicon types incFIA/incFIIK, and the
transferred 55 kbp plasmid and the 170 kbp co-integrate were of plasmid replicon types incN/
incFIIK (Table 1).
ODM analysis of the transconjugant plasmids confirmed that the 140 kbp and the 55 kbp
plasmids are the same as in the respective wild donors (Figs 4 and 5), without any major struc-
tural rearrangements, and that they harbour the blaKPC-3 gene. Also, the co-integrate 170 kbp
plasmid present in one of the transconjugants, from isolate KP2-448, was found to harbour the
blaKPC-3 gene. Based on ODM, it was possible to confirm that the 170 kbp co-integrate origi-
nate from a combination of the 55 kbp plasmid, where the blaKPC-3 gene is located, and the
136 kbp plasmid present in the wild isolate (Fig 6). Also, the location of the breakpoint in each
plasmid when forming the co-integrate could be detected, and that a smaller region of the 136
kbp plasmid was lost in the co-integration process (explaining why the 170 kbp plasmid is
smaller than the sum of the 55 kbp and 136 kbp plasmids). The 136 kbp plasmid present in the
wild isolates from patient 2 (KP2-448 and KP2-465) was not transferred alone, but only as part
of the 170 kbp co-integrate. The formation of the 170 kbp co-integrate also permitted the
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transfer of gentamicin resistance, presumably located on the 136 kbp plasmid of isolate KP2-
448, in which a MICGEN of 256 μg/mL was determined. Indeed, in the transconjugants of this
isolate, the MICGEN values raised from 0.5 μg/mL when the 55 kbp plasmid was transferred
alone, to 128 μg/mL when it formed a co-integrate with the 136 kbp plasmid (Table 1).
Discussion
Multidrug-resistant K. pneumoniae are a major clinical threat among Enterobacteriaceae, in
terms of spread of resistance to last resort antibiotics, such as carbapenems. Horizontal gene
transfer via plasmids constitutes a major pathway for the spread of antibiotic resistance and
identifying and characterizing plasmids is therefore an important part of the investigation of
resistant strains. In this study, we aimed to assess the diversity of carbapenem-resistant K.
pneumoniae in a clinical setting and the evolution of resistance through plasmid acquisition.
Here, we show that clinical K. pneumoniae isolates, collected from two distinct patients
over a period of 18 months, from the same MLST, ST147, possessed different conjugative plas-
mids harbouring the blaKPC-3 gene. The finding that all carbapenem-resistant isolates were
from the same clonal complex is not surprising since K. pneumoniae ST147 is considered an
emerging high-risk clonal lineage, primarily associated with the production of carbapenemases
[42, 43]. Although belonging to the same MLST, the isolates represented two clones that har-
boured distinct blaKPC-3 plasmids. These observations suggest that two clones harbouring the
gene blaKPC-3 colonized these patients. While no evidence of horizontal gene transfer was
detected, conjugation might have taken place since both blaKPC-3 plasmids were conjugative.
The two conjugative plasmids harbouring the blaKPC-3 gene were characterized as incFIA
(plasmid of size 140 kbp) and incN (plasmid of size 55 kbp), respectively. The association of K.
Fig 3. Intensity profiles reflecting the optical maps of the plasmids found in isolate KP3-685. (a) The 150 kbp
plasmid present in KP3-685, lacking the blaKPC-3 gene, and the 140 kbp plasmid present in KP1-080 (patient 1),
harbouring the blaKPC-3 gene (indicated by the open circle in the shaded region). Shown is the best matching
comparison, with a p-value of 0.63 (threshold for similarity set to p-value� 0.01). (b) The 80 kbp plasmid present in
KP3-685 and the 136 kbp plasmid present in KP2-448 (patient 2), both lacking the blaKPC-3 gene, and the 140 kbp
plasmid present in KP1-080 (patient 1), harbouring the blaKPC-3 gene (indicated by the open circle in the shaded
region). The intensity profiles for the 80 kbp plasmid of isolate KP3-685 and 136 kbp plasmid of isolate KP2-488 have
been shifted vertically (+1 and -1 unit, respectively) for increased visibility. Note that the intensity profile of the 140
kbp plasmid is shifted relative to the intensity profile shown in Fig 2, due to circular permutation.
https://doi.org/10.1371/journal.pone.0247058.g003
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pneumoniae ST147 with plasmids incFIA and incN has been reported before [10, 44]. The 55
kbp plasmid was in one case transferred as part of a co-integrate (of size 170 kbp), which also
was characterized as incN. The formation of incN co-integrate plasmids harbouring blaKPC-3 is
seldomly reported in the literature compared with the formation of incF co-integrate plasmids
[40, 45]. The transconjugant carrying the 170 kbp co-integrate did not only show carbapenem
resistance, but in addition a significantly higher gentamicin resistance than the transconjugant
to which the 55 kbp plasmid was transferred alone (Table 1). This finding confirms the advan-
tage of forming co-integrates in the spread of genes related to carbapenem and aminoglycoside
resistance [11].
The association of carbapenem resistance genes to the Tn4401d transposon region was pre-
viously reported in a incN plasmid from E. coli [41]. Thus, the two features of the 55 kbp incN
plasmid, that it forms co-integrate plasmids and that it shares Tn4401d with plasmids present
in other species, shows the plasticity of this plasmid and its potential to spread antibiotic resis-
tance among Enterobacteriaceae. In addition, our results show that the insertion of transposon
Fig 4. Intensity profiles reflecting the optical maps of the 140 kbp conjugative plasmid harbouring the blaKPC-3
gene. Conjugative plasmid of 140 kbp present in (a) the clinical isolate KP1-388 and the corresponding
transconjugants KP1-388_E2FC13 (F10) and KP1-388_SCC.99 (E5) and (b) the clinical isolate KP1-080 and the
corresponding transconjugant KP1-080_E2FC13 (C1) and (c) the clinical isolate KP1-349 and the corresponding
transconjugant KP1-349_E2FC13 (A1). The open circles in the shaded regions indicate the location of the blaKPC-3
gene. The circles indicating the gene location in E5 in (a) and C1 in (b) have been shifted vertically for increased
visibility.
https://doi.org/10.1371/journal.pone.0247058.g004
PLOS ONE Vertical transmission of the blaKPC-3 gene in Klebsiella pneumoniae clinical isolates
PLOS ONE | https://doi.org/10.1371/journal.pone.0247058 February 26, 2021 12 / 18
Tn4401d harbouring the blaKPC-3 gene into the Tn1331 transposon from incFIA plasmid also
lead to the spread of resistance to different classes of antibiotics, as already described [40].
An important part of this study was to demonstrate the usefulness of ODM for plasmid
characterization. For determination of plasmid profiles, PFGE is the most commonly used
technique [14, 46]. The number of plasmids, and their sizes, in each isolate determined by
ODM was consistent with the results obtained using PFGE.
The presence of antibiotic resistance genes is routinely determined by PCR-based methods
and genome sequencing. Using PCR-based methods to screen for antibiotic resistance genes,
or any other genes, gives the presence or absence of the given targets, whereas sequencing
methods provide further information on where the gene is located, i.e. on which plasmid or on
Fig 5. Intensity profiles reflecting the optical maps of the 55 kbp conjugative plasmid harbouring the blaKPC-3
gene. Conjugative plasmid of 55 kbp present in (a) the clinical isolate KP2-448 and the corresponding transconjugant
KP2-448_E2FC13 (B3) and (b) the clinical isolate KP2-465 and the corresponding transconjugant KP2-465_E2FC13
(D2). The open circles in the shaded regions indicate the location of the blaKPC-3 gene.
https://doi.org/10.1371/journal.pone.0247058.g005
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the bacterial chromosome. ODM, complemented by CRISPR/Cas9, can also be used for gene
recognition and in addition reveal where along the plasmid sequence the gene is located. Thus,
both of these results are obtained from one single experiment ODM, on the other hand, gives
both of these results from one single experiment [22], which is unique for ODM. The ODM
analysis could directly show that the gene of interest, blaKPC-3, was present on the 140 kbp plas-
mid in the isolates from patient 1 and on the 55 kbp plasmid in the isolates from patient 2.
Moreover, while the conjugation assays showed the transfer of carbapenem resistance, ODM
could confirm not only the transfer of the blaKPC-3 gene, but also the transfer of the intact plas-
mids carrying the resistance gene.
The transfer of the 55 kbp plasmid carrying the blaKPC-3 gene as a co-integrate, indicated by
the finding of a 170 kbp plasmid in one of the carbapenem-resistant transconjugant isolates,
could be verified by ODM. Moreover, not only could ODM confirm the presence of the target
gene on this novel sized plasmid, but also map the origin of the co-integrate. The intensity pro-
file of the 170 kbp co-integrate matched well with the intensity profiles of the 55 kbp plasmid
carrying the blaKPC-3 gene and another plasmid of 136 kbp present in the wild isolate that did
not carry the blaKPC-3 gene. Sequencing approaches could be used to confirm plasmid rear-
rangements, such as the formation of co-integrates, or inversions, insertions or deletions,
although the dynamic and often repetitive nature of plasmid elements many times makes the
assembly process of sequencing data non-trivial and time-consuming. Here, ODM serves as
an advantageous alternative, as this kind of dynamic rearrangements can be directly visualized
in a single, fast experiment. This study is the first example of using ODM to characterize the
formation of co-integrate plasmids during conjugation.
In the carbapenem-susceptible isolate from 2014, KP3-685, two plasmids were found, of
which one was of similar size as the 140 kbp plasmid harbouring the blaKPC-3 gene in the iso-
lates from patient 1, leading to our hypothesis that the plasmids found in this isolate potentially
could represent ancestors of the blaKPC-3 plasmids identified in the 2015 or 2016 isolates. The
ODM analysis revealed that the plasmid with size of 80 kbp in this 2014 isolate, and not the
140 kbp plasmid, shared sequence similarities with the plasmids of around 140 kbp size
observed in both patients, although not in the region where the blaKPC-3 gene was located. This
could possibly be an indication of a common plasmid origin in all the investigated isolates
before the acquisition of the carbapenem resistance gene, or, alternatively, the plasmid in iso-
late KP3-685 lost the carbapenem-resistance gene. Comparison of the intensity profiles of the
Fig 6. Intensity profiles reflecting the optical maps of the 170 kbp plasmid present in transconjugant KP2-
448_E2FC13 (B4) and the 55 kbp and 136 kbp plasmids present in the Klebsiella pneumoniae clinical isolate KP2-
448. The open circles in the shaded region indicate the blaKPC-3 gene position on the 55 kbp and 170 kbp plasmid,
respectively. The intensity profiles for the 55 kbp and 136 kbp plasmids have been shifted vertically (+1 and -1 unit,
respectively) for increased visibility.
https://doi.org/10.1371/journal.pone.0247058.g006
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two conjugative plasmids harbouring the blaKPC-3 gene (140 kbp and 55 kbp), particularly in
the region where the gene is located, did however not show any significant similarity, indicat-
ing that the evolution of antibiotic resistance in these two plasmids occurred in parallel rather
than from a common origin.
Conclusions
The results of this study showed that the five carbapenem-resistant K. pneumoniae isolates
recovered in the specific hospital from two patients and over a period of more than one year
represented two distinct clones of the same MLST group (ST147), one with two isolates and
another with three. In these two groups of isolates the blaKPC-3 gene was located on different
conjugative plasmids, with a size of 140 kbp in one and 55 kbp in the other. The plasmids were
different, as could be confirmed by ODM, with no hints of horizontal gene transfer of the
blaKPC-3 gene. Therefore, it was suggested that the transmission of carbapenem-resistant K.
pneumoniae in the hospital at the time investigated was vertical. Although high throughput
sequencing is valuable for this kind of studies, ODM has unquestionable advantages if one
considers the high speed and reliability versus the low cost of this method to distinguish plas-
mids and simultaneously identify genetic determinants. We therefore foresee that ODM can
become a standard tool in plasmid analysis.
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